Cellectis SA (CLLS) has released an update.
Cellectis SA has announced its Combined General Meeting of Shareholders set for June 28, 2024, with an agenda covering the approval of financial statements, board appointments, and various authorizations for capital adjustments and share allocations. Shareholders will review the company’s annual and consolidated financials for 2023, consider agreements with Bpifrance, and vote on board member renewals and auditor appointments. Significant proposals include authorizing share buybacks, updating company statutes, and granting the board authority to issue new shares, potentially altering the company’s capital structure.
For further insights into CLLS stock, check out TipRanks’ Stock Analysis page.
